| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |